Jennifer Anne Doudna (born February 19, 1964)[2] is an ... - dofaq.co
Jennifer Anne Doudna (born February 19, 1964)[2] is an ...Jennifer Anne Doudna (born February 19, 1964)[2] is an American biochemist known for her pioneering work in CRISPR gene editing, for which she was awarded the 2020 Nobel Prize in Chemistry along with Emmanuelle Charpentier. She is a Li Ka Shing Chancellor Chair Professor in the Department of Chemistry and the Department of Molecular and Cell Biology at the University of California, Berkeley.[3]
What's the timeline for gene edited babies? 25 years, says CRISPR pioneer Jennifer Doudna
Scientific collaborations are precarious territory for women
Limited cross-variant immunity from SARS-CoV-2 Omicron without vaccination
Most influential people in biopharma, the scientists
Karen Miga named one of TIME's 100 most influential people of 2022
Nobel Laureate Dr. Jennifer Doudna and Groundbreaking Applications of CRISPR - Research Blog
Ginsburg Symposium hosts discussions about precision medicine technologies
Making science serve humanity: Jennifer Doudna, PhD, says CRISPR gene-editing technology should be accessible to all
Biogen takes another dip into Scribe gene therapy collab with another disease target
Jennifer Doudna and Marty Chavez on where CRISPR meets Wall Street
Dynamoid secures NIH funding to bring science to the metaverse
Sixth Street taps Nobel Laureate Doudna as chief science advisor
Nobel laureate Jennifer Doudna is using CRISPR to build an network of women scientists - San Francisco Business Times
Jennifer Doudna-founded CRISPR biotech raises new cash to broaden drug development work
Nobel Prize Winner Dr. Jennifer A. Doudna to Receive Top Award from the Women in Medicine Legacy Foundation
CRISPR Co-Founder Jennifer Doudna on Future of Biotech
Nobel Prize winner to deliver science talk
UCSF-led Team Wins $112M NIH Grant to Harness Omics Tools for Antiviral Target, Drug Development
UC Berkeley loses CRISPR gene editing patent case
